Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia
- 1 April 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 302 (2-3), 117-120
- https://doi.org/10.1016/s0304-3940(01)01688-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Low GSK-3β Immunoreactivity in Postmortem Frontal Cortex of Schizophrenic PatientsAmerican Journal of Psychiatry, 2000
- Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophreniaJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Abnormalities of Wnt signalling in schizophrenia – evidence for neurodevelopmental abnormalityNeuroReport, 1998
- Human Dishevelled Genes Constitute a DHR-Containing Multigene FamilyGenomics, 1997
- WNTs modulate cell fate and behavior during vertebrate developmentTrends in Genetics, 1997
- Altered Distribution of Nicotinamide-Adenine Dinucleotide Phosphate—Diaphorase Cells in Frontal Lobe of Schizophrenics Implies Disturbances of Cortical DevelopmentArchives of General Psychiatry, 1993
- CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophreniaSynapse, 1993
- The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brainCell, 1990
- Prenatal developmental disturbances in the limbic allocortex in schizophrenicsJournal of Neural Transmission, 1986
- Gliosis in schizophrenia: A surveyBiological Psychiatry, 1986